The COVID-19 and Diabetes Assessment (CODA) Study
PI(s): Russel Rothman, Vanderbilt University Medical Center
Purpose: The research aims to address pressing questions from patients and clinicians concerning the linkage between diabetes and COVID-19. It seeks to delve into how COVID-19 impacts glycemic control issues, affects vascular function, triggers inflammation, and heightens the risk of blood clot formation among individuals with either type 1 or type 2 diabetes. Additionally, the study will investigate the influence of genomic, social, and environmental elements on metabolic function, as well as assess the effects of both COVID-19 infection and treatments on outcomes related to diabetes.
Study Design: Multi-CRN Observational Study Requiring Recruitment
PCORnet® Partners:
- Vanderbilt University Medical Center (STAR)
PaTH Partners:
- Johns Hopkins University, Hsin-Chieh “Jessica” Yeh
- University of Pittsburgh, Kathleen McTigue
Sponsor: NIDDK/NIH
Coordinating Center: Vanderbilt University Medical Center
